Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Oct 31, 2022 11:37am
69 Views
Post# 35060196

RE:RE:Wowy Wow Wow Look at them Go Now

RE:RE:Wowy Wow Wow Look at them Go NowIts a good sign when a company doesnt care about investor questions though right?

They did say they would tell investors even less though so I guess this time they did keep their word.


IainCaimbeul wrote: Six business days since I asked Stagezero and Care about this. No response from either, no surprise.
It's populated with six's all the way out to Jan 2024, tired of counting after that.

Looks like Stagezero has finally decided on $949.00 USD as the retail price, so I guess that is progress. Ichor health still does not show the price for Aristotle on their websiite but if you post an inquiry they do not follow up with an answer.

Liked2Think wrote: I guess they had to make a change on the ol "reservce a call with a case manager" site

Was it something I said?

Nope, the auto setup must be off because now you can see all of november and december.

All of Dec you have 6 calls available a day.

For November you have what looks like a max of 15 calls avaialble for the first two weeks then down to 6 for the rest.  One of their workers must have had enough and pulle the pin.

Its nice one person decided to request a call on Nov 14th.  Didnt have time for a call about cancer for the next 15 days I guess.

6 spots all through march 2023.  Thats all I care to click on

https://careoncology.com/reserve-a-call-with-a-case-manager/




<< Previous
Bullboard Posts
Next >>